Jolanta Grembecka

USPTO Granted Patents = 31 (Patent Applications = 9)

CIPO Patents = 3 (Patent Applications = 7)

EPO Patents = 11 (Patent Applications = 17)

Average Co-Inventor Count = 7.0

ph-index = 8

Forward Citations = 177(Granted Patents)

Location History:

Charlottesville, VA (US) (2015)
Ann Arbor, MI (US) (2014 - 2024)

Company Filing History:

27 out of 3,384

University of Michigan

University of Virginia Patent Foundation

patents

4. 1 out of 1,155

Vanderbilt University

patents

5. 1 out of 832,880

Other

patents

where one patent can have more than one assignee

Years Active: 2014-2025

Loading Chart...

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12466813 - PRC1 inhibitors and methods of treatment therewith (2025-11-11),

2. 12364688 - NSD family inhibitors and methods of treatment therewith (2025-07-22),

3. 12285490 - ASH1L degraders and methods of treatment therewith (2025-04-29),

4. 11883381 - ASH1L inhibitors and methods of treatment therewith (2024-01-30),

5. 11858925 - GAS41 inhibitors and methods of use thereof (2024-01-02),

6. 11833210 - ASH1L inhibitors and methods of treatment therewith (2023-12-05),

7. 11786602 - ASH1L degraders and methods of treatment therewith (2023-10-17),

8. RE49687 - Thienopyrimidine and thienopyridine compounds and methods of use thereof (2023-10-10),

9. 11673898 - Substituted inhibitors of menin-MLL and methods of use (2023-06-13),

10. 11555041 - Bridged bicyclic inhibitors of menin-MLL and methods of use (2023-01-17),

11. 11542248 - Methods and compositions for inhibiting the interaction of menin with MLL proteins (2023-01-03),

12. 11324729 - NSD family inhibitors and methods of treatment therewith (2022-05-10),

13. 11319302 - PRC1 inhibitors and methods of treatment therewith (2022-05-03),

14. 11147885 - ASH1L inhibitors and methods of treatment therewith (2021-10-19),

15. 11110177 - ASH1L degraders and methods of treatment therewith (2021-09-07),

Title: Jolanta Grembecka - Innovator from Ann Arbor

Introduction: Jolanta Grembecka is a pioneering inventor based in Ann Arbor, MI, known for her groundbreaking contributions to the field of biotechnology and pharmaceuticals.

Latest Patents: Jolanta Grembecka holds several patents related to novel drug compounds targeting specific cancer mutations, as well as innovative methods for drug delivery and personalized medicine.

Career Highlights: With a background in biochemistry and molecular biology, Grembecka has had a distinguished career working in both academic research institutions and leading pharmaceutical companies. Her work has been instrumental in advancing precision medicine approaches for cancer treatment.

Collaborations: Throughout her career, Jolanta Grembecka has collaborated with top researchers, clinicians, and industry experts to translate her innovative ideas into tangible solutions for patients. Her collaborative spirit has led to the development of cutting-edge therapies with the potential to revolutionize cancer care.

Conclusion: Jolanta Grembecka's relentless pursuit of innovation and her commitment to improving patient outcomes make her a standout figure in the world of biotechnology. Her work continues to inspire the next generation of inventors and researchers in the field.

This text is generated by artificial intelligence and may not be accurate.